The Josep Carreras Institute and the Hospital del Mar Research Institute strengthen their institutional collaboration August 21, 2025 The Josep Carreras Institute and the Hospital del Mar Research Institute strengthen their institutional collaboration
A common alteration in acute myeloid leukaemia helps cancer cells survive and holds the potential for new therapies May 05, 2025 A common alteration in acute myeloid leukaemia helps cancer cells survive and holds the potential for new therapies
Verónica Rodilla and José L. Sardina receive the Research Consolidation grant from the Spanish State Research Agency April 30, 2025 Verónica Rodilla and José L. Sardina receive the Research Consolidation grant from the Spanish State Research Agency
New CAR-T Therapy achieves positive results in a high proportion of patients with a refractory type of lymphoma April 29, 2025 New CAR-T Therapy achieves positive results in a high proportion of patients with a refractory type of lymphoma
Dr Biola M. Javierre awarded the 2024 CRIS Excellence Award April 24, 2025 Dr Biola M. Javierre awarded the 2024 CRIS Excellence Award
Dr Ari Melnick, new Director of the Josep Carreras Leukaemia Research Institute April 22, 2025 Dr Ari Melnick, new Director of the Josep Carreras Leukaemia Research Institute
New proteogenomic research links germline variants to cancer progression April 15, 2025 New proteogenomic research links germline variants to cancer progression
The Josep Carreras Institute accredited by the Scientific Foundation of the Spanish Association Against Cancer April 07, 2025 The Josep Carreras Institute accredited by the Scientific Foundation of the Spanish Association Against Cancer
Researchers find how to overcome bortezomib resistance in mantle cell lymphoma April 04, 2025 Researchers find how to overcome bortezomib resistance in mantle cell lymphoma
Common anticancer drugs may offer new hope to PTEN Hamartoma Tumour Syndrome patients March 28, 2025 Common anticancer drugs may offer new hope to PTEN Hamartoma Tumour Syndrome patients
A new CAR-T-cell therapy that tricks the tumour could increase treatment efficiency in B-cell Acute Lymphoblastic Leukaemia March 21, 2025 A new CAR-T-cell therapy that tricks the tumour could increase treatment efficiency in B-cell Acute Lymphoblastic Leukaemia
.png?locale=en)
